Orphan Europe Carbaglu® Surveillance Protocol
Sponsor: Boston Children's Hospital
A observational or N/A phase clinical study on N-acetylglutamate Synthase (NAGS) Deficiency, this trial is actively recruiting participants. The trial is conducted by Boston Children's Hospital and has accumulated 13 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Recruiting
-
Sep 2024 — Sep 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Mar 2024 — Jul 2024 [monthly]
Recruiting
-
Sep 2022 — Mar 2024 [monthly]
Recruiting
▶ Show 8 earlier versions
-
Mar 2021 — Sep 2022 [monthly]
Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Recruiting
-
Sep 2020 — Jan 2021 [monthly]
Recruiting
-
Mar 2020 — Sep 2020 [monthly]
Recruiting
-
Feb 2019 — Mar 2020 [monthly]
Recruiting
-
Jun 2018 — Feb 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Feb 2018 — Apr 2018 [monthly]
Recruiting NA
First recorded
Apr 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Boston Children's Hospital
- Icahn School of Medicine at Mount Sinai
- Nicholas Ah Mew
For direct contact, visit the study record on ClinicalTrials.gov .